| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 55.151 | 48.882 | 39.305 | 44.311 | 43.822 | 34.710 | 41.606 | 43.317 | 46.237 | 58.338 |
| Total Income - EUR | 55.151 | 48.882 | 39.474 | 44.311 | 43.822 | 34.710 | 41.606 | 43.317 | 46.329 | 58.338 |
| Total Expenses - EUR | 51.162 | 47.611 | 40.153 | 37.920 | 44.332 | 39.878 | 40.063 | 44.374 | 42.629 | 43.856 |
| Gross Profit/Loss - EUR | 3.989 | 1.271 | -679 | 6.390 | -510 | -5.168 | 1.542 | -1.057 | 3.699 | 14.483 |
| Net Profit/Loss - EUR | 2.757 | 783 | -1.074 | 5.947 | -948 | -5.515 | 1.126 | -1.490 | 3.245 | 12.855 |
| Employees | 4 | 4 | 5 | 5 | 5 | 4 | 0 | 4 | 3 | 2 |
Check the financial reports for the company - Uro-Andro-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 66.028 | 0 | 0 | 0 | 0 | 187 | 0 | 0 | 0 | 0 |
| Current Assets | 7.699 | 6.932 | 6.052 | 11.917 | 11.119 | 9.313 | 9.667 | 4.897 | 8.493 | 20.823 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.773 | 4.965 | 4.752 | 4.370 | 3.959 | 0 | 9 | 983 | 0 | 15 |
| Cash | 3.927 | 1.967 | 1.300 | 7.547 | 7.160 | 9.313 | 9.658 | 3.914 | 8.493 | 20.808 |
| Shareholders Funds | 66.338 | 5.756 | 4.585 | 10.448 | 9.298 | 3.606 | 4.653 | 3.177 | 6.412 | 19.307 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.389 | 1.176 | 1.467 | 1.469 | 1.821 | 5.894 | 5.015 | 1.720 | 2.081 | 1.516 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Uro-Andro-Med Srl